Sectra AB (publ)
Sectra AB (publ) provides solutions for medical IT and cybersecurity sectors in Sweden, the United Kingdom, the Netherlands, and rest of Europe. The company operates through Imaging IT Solutions, Secure Communications, and Business Innovation segments. The Imaging IT Solutions segment develops and sells medical IT systems and services for managing, archiving, and presenting various types of medic… Read more
Market Cap & Net Worth: Sectra AB (publ) (SECT-B)
Sectra AB (publ) (ST:SECT-B) has a market capitalization of $3.63 Billion (Skr40.73 Billion) as of March 18, 2026. Listed on the ST stock exchange, this Sweden-based company holds position #3497 globally and #13 in its home market, demonstrating a 6.68% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Sectra AB (publ)'s stock price Skr226.80 by its total outstanding shares 179564029 (179.56 Million).
Sectra AB (publ) Market Cap History: 2015 to 2026
Sectra AB (publ)'s market capitalization history from 2015 to 2026. Data shows growth from $287.61 Million to $3.63 Billion (29.37% CAGR).
Sectra AB (publ) Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Sectra AB (publ)'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.24x
Sectra AB (publ)'s market cap is 1.24 times its annual revenue
0.67x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
7.13x
Sectra AB (publ)'s market cap is 7.13 times its annual earnings
1.95x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $339.88 Million | $1.07 Billion | $125.70 Million | 0.32x | 2.70x |
| 2017 | $483.29 Million | $1.14 Billion | $152.79 Million | 0.42x | 3.16x |
| 2018 | $550.44 Million | $1.27 Billion | $198.26 Million | 0.43x | 2.78x |
| 2019 | $1.17 Billion | $1.41 Billion | $198.98 Million | 0.83x | 5.88x |
| 2020 | $2.23 Billion | $1.66 Billion | $237.35 Million | 1.34x | 9.40x |
| 2021 | $3.07 Billion | $1.63 Billion | $275.51 Million | 1.88x | 11.16x |
| 2022 | $2.32 Billion | $1.95 Billion | $314.79 Million | 1.19x | 7.37x |
| 2023 | $2.86 Billion | $2.35 Billion | $374.96 Million | 1.22x | 7.63x |
| 2024 | $4.43 Billion | $2.96 Billion | $428.39 Million | 1.49x | 10.34x |
| 2025 | $4.02 Billion | $3.24 Billion | $563.37 Million | 1.24x | 7.13x |
Competitor Companies of SECT-B by Market Capitalization
Companies near Sectra AB (publ) in the global market cap rankings as of March 18, 2026.
Key companies related to Sectra AB (publ) by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
Sectra AB (publ) Historical Marketcap From 2015 to 2026
Between 2015 and today, Sectra AB (publ)'s market cap moved from $287.61 Million to $ 3.63 Billion, with a yearly change of 29.37%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Skr3.63 Billion | -9.64% |
| 2025 | Skr4.02 Billion | -9.27% |
| 2024 | Skr4.43 Billion | +54.76% |
| 2023 | Skr2.86 Billion | +23.30% |
| 2022 | Skr2.32 Billion | -24.52% |
| 2021 | Skr3.07 Billion | +37.79% |
| 2020 | Skr2.23 Billion | +90.61% |
| 2019 | Skr1.17 Billion | +112.67% |
| 2018 | Skr550.44 Million | +13.89% |
| 2017 | Skr483.29 Million | +42.19% |
| 2016 | Skr339.88 Million | +18.17% |
| 2015 | Skr287.61 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Sectra AB (publ) was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $3.63 Billion USD |
| MoneyControl | $3.63 Billion USD |
| MarketWatch | $3.63 Billion USD |
| marketcap.company | $3.63 Billion USD |
| Reuters | $3.63 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.